#疫苗

Europe Authorizes Moderna mRNA Combo Vaccine First: A Divergence in Global Vaccine Strategy

Moderna's combined mRNA vaccine has been authorized in Europe, revealing a divergence in global vaccine strategy. Europe's proactive approach contrasts with the U.S., where political pressure has stalled application progress, forcing pharmaceutical firms to adopt flexible global strategies.

Williams·Apr 26, 2026·2 min read